Albireo Pharma Inc

NASDAQ:ALBO   3:59:54 PM EDT
29.65
+0.42 (+1.44%)
Products, Expansion

Albireo And Genpharm Announce Agreement To Commercialize Bylvay (Odevixibat) In Saudi Arabia And Gulf Region

Published: 08/18/2021 05:39 GMT
Albireo Pharma Inc (ALBO) - Albireo and Genpharm Announce Agreement to Commercialize Bylvay (odevixibat) in Saudi Arabia and Gulf Region.
Genpharm Will Be Responsible for Regulatory Filings, Reimbursement Submissions, Medical and Commercial Support for Bylvay.